InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.03
(
0.25%
)
US TECH 100
19,430.40
(
0.14%
)
Dow Jones
38,834.86
(
0.15%
)
Brent Oil
84.80
(
0.01%
)
Bitcoin
65,346.35
(
0.32%
)
Post# of 252254
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: jq1234 post# 142791

Tuesday, 05/29/2012 5:46:30 AM

Tuesday, May 29, 2012 5:46:30 AM

Post# of 252254

GSK will present dabrafenib monotherapy in ph3 melanoma result at ASCO as well. Would be interesting to see efficacy relative to Zelboraf. If I remember correctly the earlier efficacy result wasn't as striking as Zelboraf.

Thanks for the pointer, I've skipped it as the abs. isn't available yet. I don't think GSK ever presented PFS and OS data from phase II, so are you talking about phase I data?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up